Mabion S.A. (MAB.WA)

PLN 9.49

(-4.33%)

Total Liabilities Summary of Mabion S.A.

  • Mabion S.A.'s latest annual total liabilities in 2023 was 90.47 Million PLN , down -17.5% from previous year.
  • Mabion S.A.'s latest quarterly total liabilities in 2024 Q3 was 43.28 Million PLN , down -14.72% from previous quarter.
  • Mabion S.A. reported annual total liabilities of 109.66 Million PLN in 2022, down -16.24% from previous year.
  • Mabion S.A. reported annual total liabilities of 130.92 Million PLN in 2021, down -15.92% from previous year.
  • Mabion S.A. reported quarterly total liabilities of 43.28 Million PLN for 2024 Q3, down -14.72% from previous quarter.
  • Mabion S.A. reported quarterly total liabilities of 50.75 Million PLN for 2024 Q2, up 8.33% from previous quarter.

Annual Total Liabilities Chart of Mabion S.A. (2023 - 2009)

Historical Annual Total Liabilities of Mabion S.A. (2023 - 2009)

Year Total Liabilities Total Liabilities Growth
2023 90.47 Million PLN -17.5%
2022 109.66 Million PLN -16.24%
2021 130.92 Million PLN -15.92%
2020 155.7 Million PLN 15.23%
2019 135.12 Million PLN 31.73%
2018 102.57 Million PLN -24.91%
2017 136.6 Million PLN 56.09%
2016 87.51 Million PLN 32.78%
2015 65.91 Million PLN -86.36%
2014 483.32 Million PLN 106.43%
2013 234.13 Million PLN -89.07%
2012 2.14 Billion PLN 32462.22%
2011 6.57 Million PLN 282.47%
2010 1.71 Million PLN 306.55%
2009 422.94 Thousand PLN 0.0%

Peer Total Liabilities Comparison of Mabion S.A.

Name Total Liabilities Total Liabilities Difference
Bioceltix S.A. 2.26 Million PLN -3888.315%
BIOTON S.A. 215.86 Million PLN 58.086%
Captor Therapeutics Spolka Akcyjna 28.07 Million PLN -222.284%
Molecure S.A. 11.34 Million PLN -697.536%
NanoGroup S.A. 1.49 Million PLN -5971.954%
Pharmena S.A. 1.9 Million PLN -4647.009%
Poltreg S.A. 39.58 Million PLN -128.589%
Pure Biologics Spólka Akcyjna 20.84 Million PLN -334.051%
Ryvu Therapeutics S.A. 120.36 Million PLN 24.827%
Synthaverse S.A. 153.26 Million PLN 40.966%
Urteste S.A. 1.85 Million PLN -4777.52%